Kwality Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹157.11 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.28 per cent from ₹123.44 crore. This corresponds to a year-on-year *(YoY) growth of 35.81 per cent.
Operating Profit
Operating Profit stands at ₹38.76 crore, reflecting a quarter-on-quarter *(QoQ) increase of 33.10 per cent from ₹29.12 crore. This corresponds to a year-on-year *(YoY) growth of 49.71 per cent.
PBDT
PBDT stands at ₹36.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 35.89 per cent from ₹27.17 crore. This corresponds to a year-on-year *(YoY) growth of 52.81 per cent.
Profit Before Tax
Profit Before Tax stands at ₹31.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 41.66 per cent from ₹22.35 crore. This corresponds to a year-on-year *(YoY) growth of 66.02 per cent.
Net Profit
Net Profit stands at ₹25.31 crore, reflecting a quarter-on-quarter *(QoQ) increase of 58.19 per cent from ₹16.00 crore. This represents a 74.79 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Kwality Pharmaceuticals Ltd News
Kwality Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Kwality Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Kwality Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Kwality Pharmaceuticals Ltd Financial Reports
Kwality Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Kwality Pharma | 0.77% | -0.39% | 34.70% | 53.57% | 146.45% | 140.23% |
| Panacea Biotec | 3.01% | -0.74% | 10.28% | 28.57% | 17.51% | -14.31% |
| Morepen Labs. | -2.66% | 7.34% | 8.06% | 11.21% | 6.01% | -29.77% |
| Hikal | -0.92% | -14.13% | -2.77% | 1.88% | -22.36% | -49.68% |
| Sai Parenteral's | -0.93% | 4.89% | 6.04% | 25.11% | 25.11% | 25.11% |
| Indoco Remedies | -0.28% | 3.17% | -0.28% | 6.43% | -17.91% | -24.56% |
| Titan Biotech | 1.23% | 2.67% | -6.48% | 82.86% | 135.84% | 436.60% |
Company Info
Company Information
Executive Director & MD : Ramesh Arora
E D & Wholetime Director : Ajay Arora
Executive Director / Whole Time Director / CFO : Aditya Arora
E D & Wholetime Director : Geeta Arora
E D & Wholetime Director : Anju Arora
Independent Non Exe. Director : Kartik Kapur
Independent Non Exe. Director : Prashanth Vellanki
Independent Non Exe. Director : Vinod Kumar Sharma
Company Sec. & Compli. Officer : Gurpreet Kaur
Independent Non Exe. Director : Bhavesh Mahajan
Independent Non Exe. Director : Preet Mohinder S Bedi